Severe obstructive sleep apnea increases cystatin C in clinically latent renal dysfunction

Respiratory Medicine

Volumn 105, Issue 4, 2011, Pages 643-649

  Kato, Kota ^a   Takata, Yoshifumi ^a   Usui, Yasuhiro ^a   Shiina, Kazuki ^a   Asano, Kihiro ^a   Hashimura, Yuki ^a   Saruhara, Hirokazu ^a   Nishihata, Yosuke ^a   Tomiyama, Hirofumi ^a   Yamashina, Akira ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Cardiovascular risk; Clinically latent chronic kidney disease; Cystatin C; Obstructive sleep apnea; Renal function

Indexed keywords

C REACTIVE PROTEIN; CYSTATIN C;

ADULT; ANKLE BRACHIAL INDEX; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CORRELATION ANALYSIS; DIABETES MELLITUS; DIET; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; POLYSOMNOGRAPHY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SLEEP APNEA SYNDROME;

AGE FACTORS; BIOLOGICAL MARKERS; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; CYSTATIN C; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MIDDLE AGED; POLYSOMNOGRAPHY; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE;

EID: 79952313808     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2010.11.024     Document Type: Article

References (31)

1. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39:1-266.
2. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the american heart association Councils on kidney in cardiovascular disease, high blood pressure research, clinical Cardiology, and Epidemiology and Prevention. Circulation 2003;28:2154-69. (Pubitemid 37337595)
3. Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 2004;351:1285-95. (Pubitemid 39258422)
4. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004;351:1296-305.
5. Keller T, Messow CM, Lubos E, Nicaud V, Wild PS, Rupprecht HJ, et al. Cystatin C and cardiovascular death in patients with coronary artery disease and normal or mildly reduced kidney function: results from the AtheroGene study. Eur Heart J 2009; 30:314-20.
6. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000;342:1378-84. (Pubitemid 30262394)
7. Wang H, Parker JD, Newton GE, Floras JS, Mak S, Chiu KL, et al. Influence of obstructive sleep apnea on mortality in patients with heart failure. J Am Coll Cardiol 2007;49:1625-31. (Pubitemid 46551635)
8. Iseki K, Tohyama K, Matsumoto T, Nakamura H. High Prevalence of chronic kidney disease among patients with sleep related breathing disorder (SRBD). Hypertens Res 2008;31: 249-55. (Pubitemid 351461104)
9. Canales MT, Taylor BC, Ishani A, Mehra R, Steffes M, Stone KL, et al. Reduced renal function and sleep-disordered breathing in community-dwelling elderly men. Sleep Med 2008;9: 637-45.
10. Rechtschaffen A, Kales A. A Manual of Standardized Terminology, techniques and scoring Systems for sleep stages of human subjects. Los Angeles: UCLA Brain Information Service/ Brain Research Institute; 1968.
11. EEG arousals. Scoring rules and examples: a preliminary report from the sleep disorders Atlas Task Force of the american sleep disorders association. Sleep 1992;15:173-84.
12. Sleep-related breathing disorders in adults. Recommendations syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 1999;22:667-89.
13. Imai E. Equation for estimating GFR from creatinine in Japan. Nippon Rinsho 2008;66:1725-9. Review [in Japanese].
14. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009;53:982-92.
15. Grubb A, Björk J, Lindström V, Sterner G, Bondesson P, Nyman U. A cystatin C-based formula without anthropometric variables estimates glomerular filtration rate better than creatinine clearance using the Cockcroft-Gault formula. Scand J Clin Lab Invest 2005;65:153-62. (Pubitemid 40571151)
16. Grubb A, Nyman U, Björk J, Lindström V, Rippe B, Sterner G, et al. Simple cystatin C-based prediction equations for glomerular filtration rate compared with the modification of diet in renal disease prediction equation for adults and the Schwartz and the Counahan-Barratt prediction equations for children. Clin Chem 2005;51:1420-31. (Pubitemid 41060874)
17. Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis 2002;40:221-6. (Pubitemid 34827638)
18. Shlipak MG, Sarnak MJ, Katz R, Fried LF, Seliger SL, Newman AB, et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med 2005;352:2049-60. (Pubitemid 40664306)
19. Ix JH, Shlipak MG, Chertow GM, Whooley MA. Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study. Circulation 2007;115:173-9. (Pubitemid 46105715)
20. Mazer SP, Rabbani LE. Evidence for C-reactive protein's role in (CRP) vascular disease: atherothrombosis, immuno-regulation and CRP. J Thromb Thrombolysis 2004;17:95-105. (Pubitemid 39157958)
21. Koji Y, Tomiyama H, Ichihashi H, Nagae T, Tanaka N, Takazawa K, et al. Comparison of ankle-brachial pressure index and pulse wave velocity as markers of the presence of coronary artery disease in subjects with a high risk of atherosclerotic cardiovascular disease. Am J Cardiol 2004;94: 868-72. (Pubitemid 39349549)
22. Weber T, Auer J, O'Rourke MF, Kvas E, Lassnig E, Berent R, Eber B. Arterial stiffness, wave reflections, and the risk of coronary artery disease. Circulation 2004;109:184-9. (Pubitemid 38114137)
23. Zoungas S, Asmar RP. Arterial stiffness and cardiovascular outcome. Clin Exp Pharmacol Physiol 2007;34:647-51. (Pubitemid 46953113)
24. Somers VK, White DP, Amin R, Abraham WT, Costa F, Culebras A, et al. Sleep apnea and cardiovascular disease: an American heart Association/american College of Cardiology Foundation Scientific statement from the American heart association Council for high blood pressure research Professional Education Committee, Council on clinical Cardiology, stroke Council, and Council on cardiovascular Nursing. In collaboration with the National Heart, Lung, and BloodInstitute National Center on Sleep Disorders Research (National Institutes of Health). American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology; American Heart Association Stroke Council; American Heart Association Council on Cardiovascular Nursing; AmericanCollege of Cardiology Foundation. Circulation 2008;118:1080-111.
25. Shamsuzzaman AS, Gersh BJ, Somers VK. Obstructive sleep apnea: implications for cardiac and vascular disease. JAMA 2003;290:1906-14. (Pubitemid 37430608)
26. Wang H, Parker JD, Newton GE, Floras JS, Mak S, Chiu KL, et al. Influence of obstructive sleep apnea on mortality in patients with heart failure. J Am Coll Cardiol 2007;49:1632-3.
27. Shahar E, Whitney CW, Redline S, Lee ET, Newman AB, Javier Nieto F, et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 2001;163:19-25. (Pubitemid 32095247)
28. Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005;365:1046-53. (Pubitemid 40386782)
29. Sim JJ, Rasgon SA, Kujubu DA, Kumar VA, Liu IL, Shi JM, et al. Sleep apnea in early and advanced chronic kidney disease: Kaiser Permanente Southern California cohort. Chest 2009; 135:710-6.
30. Gelber RP, Kurth T, Kausz AT, Manson JE, Buring JE, Levey AS, et al. Association between body mass index and CKD in apparently healthy men. Am J Kidney Dis 2005;46:871-80. (Pubitemid 41505461)
31. Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V, et al. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 2004;140:167-74.